Published in Curr Genomics on August 01, 2010
A genome-wide analysis of common fragile sites: what features determine chromosomal instability in the human genome? Genome Res (2012) 1.37
Replication stress induces specific enrichment of RECQ1 at common fragile sites FRA3B and FRA16D. Mol Cancer (2013) 0.94
Are common fragile sites merely structural domains or highly organized "functional" units susceptible to oncogenic stress? Cell Mol Life Sci (2014) 0.90
Somatic uniparental isodisomy explains multifocality of glomuvenous malformations. Am J Hum Genet (2013) 0.88
Mechanism of replicative DNA polymerase delta pausing and a potential role for DNA polymerase kappa in common fragile site replication. J Mol Biol (2012) 0.88
Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci (2012) 0.87
Plant 45S rDNA clusters are fragile sites and their instability is associated with epigenetic alterations. PLoS One (2012) 0.87
Probing Genome Maintenance Functions of human RECQ1. Comput Struct Biotechnol J (2013) 0.86
High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome. Gynecol Oncol (2012) 0.84
Comparative oncogenomic analysis of copy number alterations in human and zebrafish tumors enables cancer driver discovery. PLoS Genet (2013) 0.84
DNA secondary structure at chromosomal fragile sites in human disease. Curr Genomics (2015) 0.82
Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy. ISRN Oncol (2012) 0.82
Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction. Neoplasia (2013) 0.81
Heterochromatin controls γH2A localization in Neurospora crassa. Eukaryot Cell (2014) 0.81
Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats. Hum Genet (2012) 0.80
Sites of genetic instability in mitosis and cancer. Ann N Y Acad Sci (2012) 0.80
Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma. World J Gastrointest Oncol (2012) 0.79
DNA topoisomerases participate in fragility of the oncogene RET. PLoS One (2013) 0.79
Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer. Oncotarget (2015) 0.78
Chromosomal bands affected by acute oil exposure and DNA repair errors. PLoS One (2013) 0.78
The role of fragile sites in sporadic papillary thyroid carcinoma. J Thyroid Res (2012) 0.77
microRNA-based cancer cell reprogramming technology. Exp Ther Med (2012) 0.77
Linking Pesticide Exposure with Pediatric Leukemia: Potential Underlying Mechanisms. Int J Mol Sci (2016) 0.77
Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas. World J Gastroenterol (2012) 0.77
Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer. Exp Biol Med (Maywood) (2014) 0.77
PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ. Oncotarget (2016) 0.76
Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. BMC Cancer (2016) 0.75
PMS2 inactivation by a complex rearrangement involving an HERV retroelement and the inverted 100-kb duplicon on 7p22.1. Eur J Hum Genet (2016) 0.75
Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma. Transl Neurosci (2015) 0.75
Association between sister chromatid exchange and double minute chromosomes in human tumor cells. Mol Cytogenet (2015) 0.75
High chromosomal instability in workers occupationally exposed to solvents and paint removers. Mol Cytogenet (2016) 0.75
The Causes and Consequences of Topological Stress during DNA Replication. Genes (Basel) (2016) 0.75
Germline large genomic alterations on 7q in patients with multiple primary cancers. Sci Rep (2017) 0.75
Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues. PLoS One (2016) 0.75
Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells. Mutat Res (2015) 0.75
Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance. Oncol Lett (2017) 0.75
The "enemies within": regions of the genome that are inherently difficult to replicate. F1000Res (2017) 0.75
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression. J Cancer Metastasis Treat (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Chromosome organization and genic expression. Cold Spring Harb Symp Quant Biol (1951) 25.51
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19
Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev (2001) 12.46
ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol (2008) 11.86
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
ATR and ATRIP: partners in checkpoint signaling. Science (2001) 7.58
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Sensing and repairing DNA double-strand breaks. Carcinogenesis (2002) 5.52
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J (1998) 5.25
Chromosome fragile sites. Annu Rev Genet (2007) 4.95
How the fanconi anemia pathway guards the genome. Annu Rev Genet (2009) 4.94
ATR regulates fragile site stability. Cell (2002) 4.74
Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell (1995) 4.35
Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science (2000) 4.17
Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol (2009) 4.15
ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev (2004) 3.44
Constitutive fragile sites and cancer. Science (1984) 3.30
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat Genet (2002) 2.81
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc Natl Acad Sci U S A (1994) 2.72
A role for common fragile site induction in amplification of human oncogenes. Cancer Cell (2002) 2.63
FRA3B and other common fragile sites: the weakest links. Nat Rev Cancer (2001) 2.61
Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol (2008) 2.58
Trinucleotide repeats affect DNA replication in vivo. Nat Genet (1997) 2.57
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet (2000) 2.56
The FHIT gene 3p14.2 is abnormal in lung cancer. Cell (1996) 2.36
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell (1997) 2.28
Replication stress induces tumor-like microdeletions in FHIT/FRA3B. Proc Natl Acad Sci U S A (2007) 2.27
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet (2005) 2.23
Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet (2001) 2.20
Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16
CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res (1995) 2.13
Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res (1990) 2.03
Hypoxia links ATR and p53 through replication arrest. Mol Cell Biol (2002) 2.03
A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell (1998) 2.00
Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev (2005) 1.97
Fragile sites still breaking. Trends Genet (1998) 1.86
RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev (2005) 1.82
Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) (2006) 1.82
FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci U S A (1996) 1.80
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn (2008) 1.80
Molecular basis for expression of common and rare fragile sites. Mol Cell Biol (2003) 1.78
Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett (2006) 1.66
Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum Mol Genet (1998) 1.65
Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res (2002) 1.62
Cancer among farmers. Occup Med (1991) 1.62
Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet (1987) 1.62
ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint. J Biol Chem (2001) 1.59
Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet (1987) 1.51
An AT-rich sequence in human common fragile site FRA16D causes fork stalling and chromosome breakage in S. cerevisiae. Mol Cell (2007) 1.51
Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene (2006) 1.50
Common fragile sites. Cancer Lett (2005) 1.48
Fragile sites are targets of diverse mutagens and carcinogens. Oncogene (1987) 1.45
Chromosome breakage and recombination at fragile sites. Am J Hum Genet (1988) 1.45
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res (2004) 1.45
BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol (2004) 1.45
WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res (2003) 1.42
Common chromosomal fragile sites and cancer: focus on FRA16D. Cancer Lett (2005) 1.36
Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int J Oncol (2010) 1.33
A variable domain of delayed replication in FRAXA fragile X chromosomes: X inactivation-like spread of late replication. Proc Natl Acad Sci U S A (1997) 1.32
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene (2002) 1.31
Werner syndrome helicase activity is essential in maintaining fragile site stability. J Cell Biol (2008) 1.31
Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett (2003) 1.30
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol (2006) 1.29
Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol (2000) 1.27
The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood (2002) 1.24
The X philes: structure-specific endonucleases that resolve Holliday junctions. Mol Microbiol (2001) 1.24
DNA polymerase epsilon: aphidicolin inhibition and the relationship between polymerase and exonuclease activity. Biochemistry (1993) 1.24
Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene (1997) 1.23
Fragile sites: breaking up over a slowdown. Curr Biol (2003) 1.23
The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab (2000) 1.19
Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics (2009) 1.17
Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res (2007) 1.15
Chromosomal instability at common fragile sites in Seckel syndrome. Am J Hum Genet (2004) 1.15
SMC1 involvement in fragile site expression. Hum Mol Genet (2005) 1.11
Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic Acids Res (2010) 1.11
DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells. Oncogene (2010) 1.09
Profile of genetic alterations and tumorigenicity of human breast cancer cells. Int J Oncol (2000) 1.06
Role of replication and CpG methylation in fragile X syndrome CGG deletions in primate cells. Am J Hum Genet (2004) 1.06
Interplay between ATM and ATR in the regulation of common fragile site stability. Oncogene (2007) 1.04
DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucleic Acids Res (2009) 1.02
Cancer incidence in the U.S. Air Force: 1989-2002. Aviat Space Environ Med (2006) 1.02
Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet Cytogenet (1986) 1.00
Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells. Mol Biol Cell (2007) 1.00
Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET/PTC rearrangements. Oncogene (2006) 0.99
Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer (2002) 0.99
Replication in mammalian cells recapitulates the locus-specific differences in somatic instability of genomic GAA triplet-repeats. Nucleic Acids Res (2006) 0.98
Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem Biophys Res Commun (2001) 0.93
Genotoxicity and carcinogenicity studies of antihypertensive agents. Mutat Res (2006) 0.93
Claspin inhibition leads to fragile site expression. Genes Chromosomes Cancer (2009) 0.92
Analysis of replication timing at the FRA10B and FRA16B fragile site loci. Chromosome Res (2000) 0.91
Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma. Hum Mol Genet (1995) 0.89
Replication timing of two human common fragile sites: FRA1H and FRA2G. Cytogenet Genome Res (2008) 0.88
Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res (1987) 0.88
Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Oncogene (2004) 0.87
Correlated fragile site expression allows the identification of candidate fragile genes involved in immunity and associated with carcinogenesis. BMC Bioinformatics (2006) 0.87
Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet (1987) 0.86
Organophosphate-based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet (2002) 0.83
L3MBTL1, a histone-methylation-dependent chromatin lock. Cell (2007) 3.70
Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat Genet (2002) 2.81
The functional interaction of the hepatitis C virus helicase molecules is responsible for unwinding processivity. J Biol Chem (2004) 1.76
Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions. Nucleic Acids Res (2002) 1.64
Functional analysis of the subunits of the chromatin assembly factor RSF. Mol Cell Biol (2003) 1.56
Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res (2010) 1.32
Self-association of collagen triple helic peptides into higher order structures. J Biol Chem (2006) 1.30
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J Med Chem (2005) 1.28
Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics (2009) 1.17
Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic Acids Res (2010) 1.11
Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo. Mol Cell (2010) 1.08
Chromatin structure can strongly facilitate enhancer action over a distance. Proc Natl Acad Sci U S A (2006) 1.00
Effect of CAT or AGG interruptions and CpG methylation on nucleosome assembly upon trinucleotide repeats on spinocerebellar ataxia, type 1 and fragile X syndrome. J Biol Chem (2004) 0.90
Sequence dependence of kinetics and morphology of collagen model peptide self-assembly into higher order structures. Protein Sci (2008) 0.90
The ATTCT repeats of spinocerebellar ataxia type 10 display strong nucleosome assembly which is enhanced by repeat interruptions. Gene (2008) 0.86
Role of DNA secondary structures in fragile site breakage along human chromosome 10. Hum Mol Genet (2013) 0.85
Friedreich's ataxia GAA.TTC duplex and GAA.GAA.TTC triplex structures exclude nucleosome assembly. J Mol Biol (2008) 0.84
Human fragile site FRA16B DNA excludes nucleosomes in the presence of distamycin. J Biol Chem (2002) 0.82
ATR preferentially interacts with common fragile site FRA3B and the binding requires its kinase activity in response to aphidicolin treatment. Mutat Res (2010) 0.81
Two breakpoint clusters at fragile site FRA3B form phased nucleosomes. Genome Res (2004) 0.79
DNA topoisomerases participate in fragility of the oncogene RET. PLoS One (2013) 0.79
The role of fragile sites in sporadic papillary thyroid carcinoma. J Thyroid Res (2012) 0.77
Drug self-association modulates the cellular bioavailability of DNA minor groove-directed terbenzimidazoles. J Med Chem (2006) 0.76
CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells. Genes Chromosomes Cancer (2011) 0.75
CAG nucleotide repeat profiles in persons with schizophrenia or schizoaffective disorders with and without tardive dyskinesia: pilot study. Am J Med Genet B Neuropsychiatr Genet (2004) 0.75